Ifp Advisors, Inc 4 D Molecular Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

  • $3.28 Billion
  • Q2 2025
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 24, 2025
BUY
$2.51 - $4.79 $0 - $0
0 New
0 $0
Q1 2025

May 05, 2025
BUY
$3.23 - $6.6 $0 - $0
0 New
0 $0
Q4 2024

Feb 04, 2025
BUY
$5.3 - $10.41 $0 - $0
0 New
0 $0

Others Institutions Holding FDMT

# of Institutions
127
Shares Held
40.6M
Call Options Held
19K
Put Options Held
38.3K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $326M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email